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LETTER TO EDITOR
Leukemoid reaction in a patient with acute lymphoblastic leukemia following the 
second chemotherapy
Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon
Osman Yokuş1, Murat Albayrak2, Aynur Albayrak3, Habip Gedik4
to 50.000 cells/µL. The examined peripheral blood 
smear appeared as similar to the chronic phase of 
CML (fig.2). A cytogenetic examination of Philadel-
phia chromosome [t(9:22] was found to be nega-
tive, therefore, CML was excluded in the patient. 
Hydroxurea was initiated once a day. Leukocytosis 
recovered to normal range after one week (fig.3) 
and bone marrow examination revealed remission. 
Cytogenetic analysis was normal and this leukocy-
tosis was determined as reactive leukemoid reac-
tion. We aimed to report this case owing to the fact 
that leukocytosis associated with G-CSF, which is 
used to increase the leukocyte count during neutro-
penia, has been reported previously but it occurred 
after second chemotherapy without G-CSF [4]. We 
know that this condition is a very rare situation.
Figure 1. Bone marrow examination of patient with acute 
lymphoblastic leukemia (diffuse blastic infiltration)
To the Editor,
The occurrence of persistent neutrophilic leukocy-
tosis above 50,000 cells/µL for reasons other than 
leukemia is defined as leukemoid reaction. Chronic 
myelogenous leukemia (CML) and chronic neutro-
philic leukemia (CNL) should be excluded, and un-
derlying diseases or causes should be examined, 
in  differential  diagnosis. The  most  commonly  ob-
served causes of leukemoid reactions are severe 
infections, intoxications, malignancies, severe hem-
orrhage, or acute hemolysis [1]. J Clin Exp Invest 
2013; 4 (2): 262-263
Rarely, leukemoid reaction can be seen in pa-
tients with acute leukemia subsequent to chemo-
therapy, as seen in our patient with acute lympho-
blastic leukemia subsequent to pancytopenia due to 
chemotherapy [2,3]. A complete blood count of the 
patient was recovered subsequent to the develop-
ment of leukemoid reaction.
The patient with precursor B cell acute lympho-
blastic leukemia (fig.1) was treated with Standard 
hyper  CVAD1  (Cyclophosphamide  and  mesna: 
2x300 mg/m2/day (D), D1-3; Doxorubicine 50 mg/
m2/day, D4; Vincristine 1,4 mg/m2/day, D4 and D11; 
Dexamethasone 40 mg/day, D1-4 and D11-14) and 
then  CVAD2  regimen  (Methotrexate  1  gr/m2/day, 
D1; Cytosine arabinoside 2x3 gr/m2/day, D2-3 and 
Calcium folinate, first dose 50 mg after six hours 15 
mg/dose every six hours, for a total of 8 doses) as 
second chemotherapy. None of the chemotherapy 
regimens included G-CSF. On the twentieth day of 
the second chemotherapy, the leukocyte count rose Yokuş et al. Leukemoid reaction in ALL 263
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Figüre 2. Peripheral blood smear similar to chronic phase 
myeloid leukemia
Figure 3. Peripheral blood smear was return to normal 
appearance after treatment of hydroxyurea
CML and leukemoid pictures tend to be con-
fused. Therefore, these two almost identical condi-
tions must be distinguished through a histological 
evaluation  of  bone  biopsy  and  immunochemical 
staining [5,6]. It has been reported that in a case 
with systemic lupus erythrosis, deep myelosuppres-
sion occurred due to low dose methotrexate admin-
istered for arthritis, and leukemoid reaction devel-
oped after the drug was discontinued [7]. The fact 
that leukemoid reaction may occur due to G-CSF-
producing tumors, and the said picture could remit 
with treatment of the tumor, was demonstrated [8].
Consequently, the development of leukocytosis 
due to leukemoid reaction subsequent to chemo-
therapy without G-CSF in patients with acute leuke-
mia should be kept in mind during the treatment of 
leukemia. Written, informed consent was obtained 
from the patient. 
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